Form 4: Monte Rosa Therapeutics Officer Sells Shares to Cover Tax Obligations

Monte Rosa Therapeutics' Principal Accounting Officer, Edmund Dunn, sold 2,062 shares of common stock to satisfy tax withholding obligations related to restricted stock unit vesting.

Summary

• Edmund Dunn, Principal Accounting Officer of Monte Rosa Therapeutics, Inc. (GLUE), reported a sale of common stock.
• The transaction occurred on June 3, 2025.
• A total of 2,062 shares were sold at a weighted average price of $4.4493 per share.
• The sale was non-discretionary and was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following this transaction, Mr. Dunn directly beneficially owns 23,732 shares of Monte Rosa Therapeutics common stock.

Sentiment

Score: 5

Explanation: Neutral. The filing reports a routine, non-discretionary sale of shares to cover tax obligations related to RSU vesting, which is a common occurrence and does not reflect a positive or negative sentiment regarding the company's prospects.

Future Outlook

NA

Management Comments

• "Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person."

Industry Context

NA

Stakeholder Impact

• Minimal. This is a routine insider transaction for tax purposes and is unlikely to have a significant direct impact on shareholders, employees, customers, suppliers, or creditors beyond standard disclosure.

Key Dates

Keywords

Monte Rosa Therapeutics, GLUE, Form 4, Insider Trading, Stock Sale, Tax Withholding, Restricted Stock Units, Edmund Dunn, Principal Accounting Officer, Beneficial Ownership